Engineering the Hematopoietic System to Treat Non-Hematological Disorders
Explore how the hematopoietic system can be engineered to produce, secrete, and deliver therapeutic proteins to multiple organs—including the central nervous system—with Dr. Natalia Gomez-Ospina of Stanford University. This webinar was hosted by LabRoots scientific social network and sponsored by STEMCELL Technologies.
Publish Date:
February 03, 2020
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
Publish Date: June 26, 2018 -
Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
Publish Date: November 28, 2018 -
Optimized Workflows for High-Efficiency Genome Editing in Stem and Primary Cell Types
Publish Date: September 09, 2019
Explore Our Products
-
STEMdiff™ Microglia Differentiation Kit
Differentiation kit for the generation of microglia precursors from human ES and iPS cell-derived hematopoietic progenitor cells -
STEMdiff™ Microglia Maturation Kit
Maturation kit for the generation of microglia from human ES and iPS cell-derived microglia precursors -
Serum-free medium for culture and expansion of hematopoietic cells -
Methylcellulose-based medium with recombinant cytokines for human cells
